Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HOCM - Hypertrophic Obstructive Cardiomyopathy”

116 trials

Showing 20 of 116 results

Not applicableLooking for participantsNCT07006493
What this trial is testing

REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd 124
Testing effectiveness (Phase 2)UnknownNCT00430833
What this trial is testing

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Charles University, Czech Republic
Not applicableEnded earlyNCT06775886
What this trial is testing

Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Montefiore Medical Center 1
Early research (Phase 1)Study completedNCT00001396
What this trial is testing

Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableLooking for participantsNCT07150299
What this trial is testing

Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy \(HOCM\)
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT01447654
What this trial is testing

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Henning Bundgaard 130
Testing effectiveness (Phase 2)Study completedNCT03953989
What this trial is testing

Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy

Who this might be right for
HCM - Hypertrophic Non-Obstructive Cardiomyopathy
IRCCS San Raffaele 26
Testing effectiveness (Phase 2)Study completedNCT00035386
What this trial is testing

Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)UnknownNCT01696370
What this trial is testing

Trimetazidine Therapy in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
University College, London 90
Not applicableLooking for participantsNCT04684290
What this trial is testing

Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
St. Antonius Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07021976
What this trial is testing

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 216
Early research (Phase 1)Study completedNCT05879523
What this trial is testing

A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 76
Not applicableUnknownNCT06224621
What this trial is testing

Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
China National Center for Cardiovascular Diseases 120
Testing effectiveness (Phase 2)Ended earlyNCT05556343
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic
Bristol-Myers Squibb 18
Testing effectiveness (Phase 2)Study completedNCT04826185
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 67
Not applicableLooking for participantsNCT07361289
What this trial is testing

Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

Who this might be right for
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 500
Not applicableActive Not RecruitingNCT07107373
What this trial is testing

Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol-Myers Squibb 150
Not applicableActive Not RecruitingNCT06372457
What this trial is testing

COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Bristol-Myers Squibb 500
Not applicableStudy completedNCT06598995
What this trial is testing

Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Myocardial BridgingObstructive Hypertrophic CardiomyopathyAtrial Fibrillation (AF)
Chinese Academy of Medical Sciences, Fuwai Hospital 968
Not applicableStudy completedNCT00001530
What this trial is testing

Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic
National Heart, Lung, and Blood Institute (NHLBI) 120
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation